First in-human trials of rovalpituzumab for SCLC
First in-human trials of rovalpituzumab for SCLC
ASCO 2016: Plenary Session Review
Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery
Latest in hepatocellular carcinoma treatments
Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin
Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin
Mechanistic studies of DNA repair
Use of novel agents in childhood ALL
Relapsed Hodgkin lymphoma in PET positive patients
First outcome results from MINDACT breast cancer clinical trial
A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer
5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates